Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K et al (2012)
If the July meeting results in a structured, prescription-only compounding framework with appropriate quality standards, that is a net improvement for patient safety regardless of where one sits politically on the question of regulatory scope
Rozanolixizumab was generated by immunizing mice and rats using both soluble truncated human FcRn and cell-bound human FcRn on fibroblasts, followed by sampling of V regions and humanization [124]
Honestly, there are compelling arguments on both sides, and the 'right' answer often depends on the specific protocol and research objectives
These products are not intended for human consumption, therapeutic use, or administration to any living organism